CN114931638A - BFO-Zein/EC magnetic composite membrane material and preparation method and application thereof - Google Patents
BFO-Zein/EC magnetic composite membrane material and preparation method and application thereof Download PDFInfo
- Publication number
- CN114931638A CN114931638A CN202210566407.5A CN202210566407A CN114931638A CN 114931638 A CN114931638 A CN 114931638A CN 202210566407 A CN202210566407 A CN 202210566407A CN 114931638 A CN114931638 A CN 114931638A
- Authority
- CN
- China
- Prior art keywords
- zein
- bfo
- magnetic composite
- magnetic
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920002494 Zein Polymers 0.000 title claims abstract description 70
- 230000005291 magnetic effect Effects 0.000 title claims abstract description 70
- 239000005019 zein Substances 0.000 title claims abstract description 70
- 229940093612 zein Drugs 0.000 title claims abstract description 70
- 239000000463 material Substances 0.000 title claims abstract description 35
- 239000002131 composite material Substances 0.000 title claims abstract description 28
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 239000012528 membrane Substances 0.000 title claims description 10
- 239000002105 nanoparticle Substances 0.000 claims abstract description 27
- 239000000835 fiber Substances 0.000 claims abstract description 21
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims abstract description 20
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims abstract description 20
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims abstract description 20
- 239000005642 Oleic acid Substances 0.000 claims abstract description 20
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims abstract description 20
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims abstract description 20
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid group Chemical group C(CCCCCCC\C=C/CCCCCCCC)(=O)O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims abstract description 20
- 239000003814 drug Substances 0.000 claims abstract description 13
- 230000004048 modification Effects 0.000 claims abstract description 13
- 238000012986 modification Methods 0.000 claims abstract description 13
- 238000004512 die casting Methods 0.000 claims abstract description 5
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 60
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 26
- 238000002156 mixing Methods 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- WDIHJSXYQDMJHN-UHFFFAOYSA-L barium chloride Chemical compound [Cl-].[Cl-].[Ba+2] WDIHJSXYQDMJHN-UHFFFAOYSA-L 0.000 claims description 14
- 229910001626 barium chloride Inorganic materials 0.000 claims description 14
- 229910021578 Iron(III) chloride Inorganic materials 0.000 claims description 13
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 claims description 13
- 239000002243 precursor Substances 0.000 claims description 12
- 238000003756 stirring Methods 0.000 claims description 12
- 229910001868 water Inorganic materials 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 11
- 239000000243 solution Substances 0.000 claims description 11
- 239000001856 Ethyl cellulose Substances 0.000 claims description 9
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims description 9
- 238000001354 calcination Methods 0.000 claims description 9
- 229920001249 ethyl cellulose Polymers 0.000 claims description 9
- 235000019325 ethyl cellulose Nutrition 0.000 claims description 9
- 239000011259 mixed solution Substances 0.000 claims description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 8
- 239000007789 gas Substances 0.000 claims description 6
- 230000001681 protective effect Effects 0.000 claims description 6
- 239000007864 aqueous solution Substances 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 4
- 229910052757 nitrogen Inorganic materials 0.000 claims description 4
- 239000001257 hydrogen Substances 0.000 claims description 3
- 229910052739 hydrogen Inorganic materials 0.000 claims description 3
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 3
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 claims 2
- FBAFATDZDUQKNH-UHFFFAOYSA-M iron chloride Chemical compound [Cl-].[Fe] FBAFATDZDUQKNH-UHFFFAOYSA-M 0.000 claims 1
- 230000008685 targeting Effects 0.000 abstract description 10
- 229940079593 drug Drugs 0.000 abstract description 9
- AJCDFVKYMIUXCR-UHFFFAOYSA-N oxobarium;oxo(oxoferriooxy)iron Chemical compound [Ba]=O.O=[Fe]O[Fe]=O.O=[Fe]O[Fe]=O.O=[Fe]O[Fe]=O.O=[Fe]O[Fe]=O.O=[Fe]O[Fe]=O.O=[Fe]O[Fe]=O AJCDFVKYMIUXCR-UHFFFAOYSA-N 0.000 abstract description 4
- 239000006185 dispersion Substances 0.000 abstract description 3
- 230000000052 comparative effect Effects 0.000 description 7
- 230000005415 magnetization Effects 0.000 description 6
- 239000008367 deionised water Substances 0.000 description 4
- 229910021641 deionized water Inorganic materials 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 238000001878 scanning electron micrograph Methods 0.000 description 4
- 231100000987 absorbed dose Toxicity 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 230000002269 spontaneous effect Effects 0.000 description 3
- 108010061711 Gliadin Proteins 0.000 description 2
- 241000209149 Zea Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 230000002459 sustained effect Effects 0.000 description 2
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 238000002441 X-ray diffraction Methods 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000010894 electron beam technology Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000005294 ferromagnetic effect Effects 0.000 description 1
- 238000009093 first-line therapy Methods 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 239000006249 magnetic particle Substances 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000003075 superhydrophobic effect Effects 0.000 description 1
- 238000002626 targeted therapy Methods 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Preparation (AREA)
Abstract
本发明属于复合材料技术领域,本发明公开了一种BFO‑Zein/EC磁性复合膜材料及其制备方法与应用。本发明钡铁氧体纳米颗粒进行油酸修饰,然后将其与改性玉米醇溶蛋白纤维混合搅拌,分散均匀后放入模具压铸成膜并进行充磁处理即得到BFO‑Zein/EC磁性膜。油酸修饰改善了钡铁氧体纳米颗粒的分散程度,并促进其与改性玉米醇溶蛋白纤维更好的结合。本发明的磁性膜材料与传统外源磁场诱导靶向材料相比极大的简化了治疗步骤和成本,且具有良好的生物相容性、自降解性以及稳定的结构和磁性,可应用于医学领域的药物靶向。
The invention belongs to the technical field of composite materials, and discloses a BFO-Zein/EC magnetic composite film material and a preparation method and application thereof. The barium ferrite nanoparticles of the present invention are modified with oleic acid, then mixed and stirred with the modified zein fibers, dispersed evenly, put into a mold for die-casting to form a film, and magnetized to obtain a BFO-Zein/EC magnetic film . Oleic acid modification improved the dispersion of barium ferrite nanoparticles and promoted their better binding to modified zein fibers. Compared with traditional exogenous magnetic field-induced targeting materials, the magnetic film material of the present invention greatly simplifies treatment steps and costs, has good biocompatibility, self-degradability, stable structure and magnetic properties, and can be applied to medicine drug targeting in the field.
Description
技术领域technical field
本发明涉及复合材料技术领域,尤其涉及一种BFO-Zein/EC磁性复合膜材料及其制备方法与应用。The invention relates to the technical field of composite materials, in particular to a BFO-Zein/EC magnetic composite film material and a preparation method and application thereof.
背景技术Background technique
磁性药物靶向治疗是利用磁场使具有磁响应的药物聚集在靶部位,提高靶部位药物的浓度,降低药物对正常组织的毒性和副作用的一种治疗方法。目前体内磁性药物靶向多采用体外强磁场诱导,但是体外强磁场诱导存在治疗步骤繁琐、所需设备复杂、治疗成本昂贵等问题。自发磁场诱导靶向膜材料有望消除或改善体外强磁场诱导治疗存在的缺陷。因此,发展自发磁场诱导靶向膜材料并将其用于磁性药物靶向中成为本领域亟需。Magnetic drug targeted therapy is a treatment method that uses a magnetic field to gather magnetically responsive drugs at the target site, increase the concentration of the drug at the target site, and reduce the toxicity and side effects of the drug to normal tissues. At present, magnetic drug targeting in vivo is mostly induced by in vitro strong magnetic field, but in vitro induction by strong magnetic field has problems such as cumbersome treatment steps, complicated equipment, and expensive treatment costs. Spontaneous magnetic field induction of targeted membrane materials is expected to eliminate or improve the defects of in vitro strong magnetic field induction therapy. Therefore, the development of spontaneous magnetic field-induced targeting membrane materials and their use in magnetic drug targeting has become an urgent need in the art.
发明内容SUMMARY OF THE INVENTION
有鉴于此,本发明提供了一种BFO-Zein/EC磁性复合膜材料及制备方法与应用,解决了目前自发磁场诱导靶向膜材料的研究存在空白的问题。In view of this, the present invention provides a BFO-Zein/EC magnetic composite membrane material, a preparation method and application, and solves the problem of blanks in the current research on spontaneous magnetic field-induced targeting membrane materials.
为了达到上述目的,本发明采用如下技术方案:In order to achieve the above object, the present invention adopts the following technical solutions:
本发明提供一种BFO-Zein/EC磁性复合膜材料的制备方法,包括如下步骤:The invention provides a preparation method of a BFO-Zein/EC magnetic composite film material, comprising the following steps:
S1:将氯化铁、氯化钡、氢氧化钠、油酸和水混合,从所得混合液中分离出前驱体纳米颗粒煅烧后得到BaFe12O19纳米颗粒;S1: mixing ferric chloride, barium chloride, sodium hydroxide, oleic acid and water, separating the precursor nanoparticles from the obtained mixed solution and calcining to obtain BaFe 12 O 19 nanoparticles;
S2:将玉米醇溶蛋白、乙基纤维素和乙醇水溶液混合,进行辐照改性,得到改性玉米醇溶蛋白纤维;S2: mixing zein, ethyl cellulose and an aqueous ethanol solution, and performing irradiation modification to obtain modified zein fibers;
S3:将BaFe12O19纳米颗粒和改性玉米醇溶蛋白纤维混合,充磁得到BFO-Zein/EC磁性复合膜;S3: mixing BaFe 12 O 19 nanoparticles and modified zein fibers, and magnetizing to obtain a BFO-Zein/EC magnetic composite film;
步骤S1和步骤S2无顺序要求。Step S1 and step S2 have no sequence requirement.
作为优选,所述步骤S1中,氯化铁、氯化钡、氢氧化钠、油酸和水混合的混合方式为:先将氯化铁、氯化钡和水混合,加入氢氧化钠,然后搅拌混合3~5h后加入油酸。Preferably, in the step S1, the mixing method of ferric chloride, barium chloride, sodium hydroxide, oleic acid and water is as follows: first, ferric chloride, barium chloride and water are mixed, sodium hydroxide is added, and then After stirring and mixing for 3 to 5 hours, oleic acid was added.
作为优选,所述步骤S1中,氯化钡和氯化铁的摩尔比为1:9~14,所述混合液中油酸的体积浓度为5~50mL/L,所述混合液中氢氧化钠的质量浓度为20~200g/L。Preferably, in the step S1, the molar ratio of barium chloride and ferric chloride is 1:9 to 14, the volume concentration of oleic acid in the mixed solution is 5 to 50 mL/L, and the sodium hydroxide in the mixed solution The mass concentration of 20 ~ 200g/L.
作为优选,所述步骤S1中,在40~80℃下加入氢氧化钠。Preferably, in the step S1, sodium hydroxide is added at 40-80°C.
作为优选,所述步骤S1中,煅烧的温度为700~1100℃,煅烧的时间为1~3h。Preferably, in the step S1, the calcination temperature is 700-1100°C, and the calcination time is 1-3 hours.
作为优选,所述步骤S2中,玉米醇溶蛋白和乙基纤维素的质量比为2~4:1,玉米醇溶蛋白和乙醇水溶液的质量体积比为1~3g:10mL,乙醇水溶液中乙醇的体积浓度为60~80%。Preferably, in the step S2, the mass ratio of zein and ethyl cellulose is 2-4:1, the mass-volume ratio of zein and the aqueous ethanol solution is 1-3 g: 10 mL, and the ethanol in the aqueous ethanol solution is 1-3 g: 10 mL. The volume concentration of 60 to 80%.
作为优选,所述步骤S2中,辐照改性在保护气体下进行,所述保护气体为氮气或氢气,辐照剂量为50~100KGy。Preferably, in the step S2, the irradiation modification is performed under a protective gas, the protective gas is nitrogen or hydrogen, and the irradiation dose is 50-100 KGy.
作为优选,所述步骤S3中,BaFe12O19纳米颗粒和改性玉米醇溶蛋白纤维质量比为1~3:1;充磁前,对BaFe12O19纳米颗粒和改性玉米醇溶蛋白纤维混合得到的混合物进行压铸成型;充磁的磁场强度为0.5~5T。Preferably, in the step S3, the mass ratio of the BaFe 12 O 19 nanoparticles and the modified zein fibers is 1-3:1; before magnetization, the BaFe 12 O 19 nanoparticles and the modified zein fibers are The mixture obtained by mixing the fibers is die-casted; the magnetic field strength for magnetization is 0.5-5T.
本发明还提供了所述BFO-Zein/EC磁性复合膜材料的制备方法制备得到的BFO-Zein/EC磁性复合膜材料。The present invention also provides a BFO-Zein/EC magnetic composite film material prepared by the method for preparing the BFO-Zein/EC magnetic composite film material.
本发明还提供了所述BFO-Zein/EC磁性复合膜材料在制备磁性药物中的应用。The invention also provides the application of the BFO-Zein/EC magnetic composite film material in the preparation of magnetic medicine.
经由上述的技术方案可知,与现有技术相比,本发明有益效果如下:As can be seen from the above-mentioned technical solutions, compared with the prior art, the beneficial effects of the present invention are as follows:
本发明所述BaFe12O19具有良好的磁性能、稳定性及安全性,通过油酸修饰后能够均匀分散于膜中,且结合紧密;而玉米醇溶蛋白(Zein)和乙基纤维素(EC)作为天然高分子材料,具有良好的生物相容性和成膜性,再通过交联改性处理使其负载量大大提升,并能保持结构的稳定;The BaFe 12 O 19 of the present invention has good magnetic properties, stability and safety, can be uniformly dispersed in the film after being modified by oleic acid, and is tightly bound; while zein (Zein) and ethyl cellulose ( EC), as a natural polymer material, has good biocompatibility and film-forming properties, and then through the cross-linking modification treatment, the loading capacity is greatly increased, and the structure can be kept stable;
本发明采用电子束辐照法对材料进行交联改性处理,该方法具有环境友好、可连续化操作、批量处理、成本低、对基材损害小等优点,并且还能达到杀菌的效果,大大节省了步骤;The invention adopts the electron beam irradiation method to carry out the cross-linking modification treatment on the material, and the method has the advantages of environmental friendliness, continuous operation, batch processing, low cost, little damage to the substrate, etc., and can also achieve the effect of sterilization, Saves a lot of steps;
本发明所述方法得到的磁性膜材料结构,磁性在较长时间内均能保持稳定,对铁磁性颗粒有明显的吸附聚集作用,对内源磁性靶向的发展有积极的意义,可用于慢性疾病的体内持续药物靶向。The magnetic film material structure obtained by the method of the invention can maintain stable magnetic properties for a long time, has obvious adsorption and aggregation effect on ferromagnetic particles, has positive significance for the development of endogenous magnetic targeting, and can be used for chronic In vivo sustained drug targeting of disease.
附图说明Description of drawings
为了更清楚地说明本发明实施例或现有技术中的技术方案,下面将对实施例或现有技术描述中所需要使用的附图作简单地介绍,显而易见地,下面描述中的附图仅仅是本发明的实施例,对于本领域普通技术人员来讲,在不付出创造性劳动的前提下,还可以根据提供的附图获得其他的附图。In order to explain the embodiments of the present invention or the technical solutions in the prior art more clearly, the following briefly introduces the accompanying drawings that need to be used in the description of the embodiments or the prior art. Obviously, the accompanying drawings in the following description are only It is an embodiment of the present invention. For those of ordinary skill in the art, other drawings can also be obtained according to the provided drawings without creative work.
图1为本发明实施例1、对比例1~2所得材料的XRD图;Fig. 1 is the XRD pattern of the material obtained in Example 1 of the present invention and Comparative Examples 1-2;
图2为本发明实施例1、对比例1~2所得材料的SEM图,其中,(a)为对比例2所得BFONPs的SEM图,(b)为BFO-Zein/EC磁性膜的SEM图,(c)为BFO-Zein磁性膜的SEM图;2 is the SEM images of the materials obtained in Example 1 and Comparative Examples 1 to 2 of the present invention, wherein (a) is the SEM image of the BFONPs obtained in Comparative Example 2, and (b) is the SEM image of the BFO-Zein/EC magnetic film, (c) is the SEM image of the BFO-Zein magnetic film;
图3为本发明实施例1、对比例1~2所得材料的VSM图。3 is a VSM diagram of the materials obtained in Example 1 and Comparative Examples 1-2 of the present invention.
具体实施方式Detailed ways
本发明提供一种BFO-Zein/EC磁性复合膜材料的制备方法,包括如下步骤:The invention provides a preparation method of a BFO-Zein/EC magnetic composite film material, comprising the following steps:
S1:将氯化铁、氯化钡、氢氧化钠、油酸和水混合,从所得混合液中分离出前驱体纳米颗粒煅烧后得到BaFe12O19纳米颗粒;S1: mixing ferric chloride, barium chloride, sodium hydroxide, oleic acid and water, separating the precursor nanoparticles from the obtained mixed solution and calcining to obtain BaFe 12 O 19 nanoparticles;
S2:将玉米醇溶蛋白、乙基纤维素和乙醇水溶液混合,进行辐照改性,得到改性玉米醇溶蛋白纤维;S2: mixing zein, ethyl cellulose and an aqueous ethanol solution, and performing irradiation modification to obtain modified zein fibers;
S3:将BaFe12O19纳米颗粒和改性玉米醇溶蛋白纤维混合,充磁得到BFO-Zein/EC磁性复合膜;S3: mixing BaFe 12 O 19 nanoparticles and modified zein fibers, and magnetizing to obtain a BFO-Zein/EC magnetic composite film;
步骤S1和步骤S2无顺序要求。Step S1 and step S2 have no sequence requirement.
在本发明中,所述步骤S1中,前驱体纳米颗粒煅烧前进行离心干燥处理;所述离心干燥的转速优选为4000~12000r/min,进一步优选为8000~11000r/min;离心干燥的温度优选为55~90℃,进一步优选为58~85℃;离心干燥的时间优选为10~14h,进一步优选为11~13h。In the present invention, in the step S1, centrifugal drying is performed before the precursor nanoparticles are calcined; the rotational speed of the centrifugal drying is preferably 4000-12000 r/min, more preferably 8000-11000 r/min; the temperature of the centrifugal drying is preferably The temperature is 55-90°C, more preferably 58-85°C; the centrifugal drying time is preferably 10-14h, more preferably 11-13h.
在本发明中,所述步骤S1中,氯化铁、氯化钡、氢氧化钠、油酸和水混合的混合方式为:先将氯化铁、氯化钡和水混合,加入氢氧化钠,然后搅拌混合3~5h后加入油酸;In the present invention, in the step S1, the mixing method of ferric chloride, barium chloride, sodium hydroxide, oleic acid and water is as follows: first, ferric chloride, barium chloride and water are mixed, and sodium hydroxide is added. , and then stir and mix for 3 to 5 hours and then add oleic acid;
所述搅拌混合的时间优选为3.5~4.5h,进一步优选为220~250min。The stirring and mixing time is preferably 3.5-4.5 h, more preferably 220-250 min.
在本发明中,所述步骤S1中,氯化铁优选为包含结晶水的氯化铁,进一步优选为FeCl3·6H2O;所述氯化钡优选为包含结晶水的氯化钡,进一步优选为BaCl2·2H2O。In the present invention, in the step S1, the ferric chloride is preferably ferric chloride containing crystal water, more preferably FeCl 3 ·6H 2 O; the barium chloride is preferably barium chloride containing crystal water, further BaCl 2 ·2H 2 O is preferred.
在本发明中,所述步骤S1中,氯化钡和氯化铁的摩尔比优选为1:9~14,进一步优选为1:10~13;所述混合液中油酸的体积浓度优选为5~50mL/L,进一步优选为10~40mL/L;所述混合液中氢氧化钠的质量浓度优选为20~200g/L,进一步优选为50~150g/L。In the present invention, in the step S1, the molar ratio of barium chloride and ferric chloride is preferably 1:9-14, more preferably 1:10-13; the volume concentration of oleic acid in the mixed solution is preferably 5 ~50mL/L, more preferably 10~40mL/L; the mass concentration of sodium hydroxide in the mixed solution is preferably 20~200g/L, more preferably 50~150g/L.
在本发明中,所述步骤S1中,优选为在40~80℃下加入氢氧化钠,进一步优选为在50~70℃下加入氢氧化钠。In the present invention, in the step S1, sodium hydroxide is preferably added at 40-80°C, more preferably sodium hydroxide is added at 50-70°C.
在本发明中,所述步骤S1中,煅烧的温度优选为700~1100℃,进一步优选为800~1000℃;煅烧的时间优选为1~3h,进一步优选为1.5~2.5h。In the present invention, in the step S1, the calcination temperature is preferably 700-1100°C, more preferably 800-1000°C; the calcination time is preferably 1-3h, more preferably 1.5-2.5h.
在本发明中,所述步骤S2中,玉米醇溶蛋白和乙基纤维素的质量比优选为2~4:1,进一步优选为2.5~3.5:1;玉米醇溶蛋白和乙醇水溶液的质量体积比优选为1~3g:10mL,进一步优选为1.5~2.5g:10mL;乙醇水溶液中乙醇的体积浓度优选为60~80%,进一步优选为65~75%。In the present invention, in the step S2, the mass ratio of zein and ethyl cellulose is preferably 2-4:1, more preferably 2.5-3.5:1; the mass volume of zein and ethanol aqueous solution The ratio is preferably 1-3 g:10 mL, more preferably 1.5-2.5 g:10 mL; the volume concentration of ethanol in the ethanol aqueous solution is preferably 60-80%, more preferably 65-75%.
在本发明中,所述步骤S2中,辐照改性在保护气体下进行,所述保护气体优选为氮气或氢气,进一步优选为氮气;辐照剂量优选为50~100KGy,进一步优选为60~80KGy。In the present invention, in the step S2, the irradiation modification is carried out under a protective gas, and the protective gas is preferably nitrogen or hydrogen, more preferably nitrogen; the irradiation dose is preferably 50-100KGy, more preferably 60- 80KGy.
在本发明中,所述步骤S3中,BaFe12O19纳米颗粒和改性玉米醇溶蛋白纤维质量比优选为1~3:1,进一步优选为1.5~2.5:1;充磁前,对BaFe12O19纳米颗粒和改性玉米醇溶蛋白纤维混合得到的混合物进行压铸成型;充磁的磁场强度优选为0.5~5T,进一步优选为1~4T。In the present invention, in the step S3, the mass ratio of BaFe 12 O 19 nanoparticles and modified zein fibers is preferably 1-3:1, more preferably 1.5-2.5:1; The mixture obtained by mixing 12 O 19 nanoparticles and modified zein fibers is subjected to die casting; the magnetic field strength for magnetization is preferably 0.5-5T, more preferably 1-4T.
本发明还提供了所述BFO-Zein/EC磁性复合膜材料的制备方法制备得到的BFO-Zein/EC磁性复合膜材料。The present invention also provides a BFO-Zein/EC magnetic composite film material prepared by the method for preparing the BFO-Zein/EC magnetic composite film material.
本发明还提供了所述BFO-Zein/EC磁性复合膜材料在制备磁性药物中的应用。The invention also provides the application of the BFO-Zein/EC magnetic composite film material in the preparation of magnetic medicine.
下面结合实施例对本发明提供的技术方案进行详细的说明,但是不能把它们理解为对本发明保护范围的限定。The technical solutions provided by the present invention will be described in detail below with reference to the embodiments, but they should not be construed as limiting the protection scope of the present invention.
实施例1Example 1
将16.2g FeCl3·6H2O和1.465g BaCl2·2H2O溶解在100mL去离子水中,在60℃下加入10g氢氧化钠持续搅拌4h后加入2mL油酸继续搅拌1h,得前驱体;将所得前驱体以5000r/min、80℃离心干燥12h后在900℃下煅烧2h得到BaFe12O19纳米颗粒;Dissolve 16.2g FeCl 3 ·6H 2 O and 1.465g BaCl 2 ·2H 2 O in 100mL deionized water, add 10g sodium hydroxide at 60°C and continue stirring for 4h, then add 2mL oleic acid and continue stirring for 1h to obtain the precursor; The obtained precursor was centrifuged and dried at 5000 r/min at 80 °C for 12 h, and then calcined at 900 °C for 2 h to obtain BaFe 12 O 19 nanoparticles;
将2g玉米醇溶蛋白与0.5g乙基纤维素溶解在10mL体积浓度为70%的乙醇水溶液中充N2装袋并进行辐照改性,吸收剂量为80kGy,之后将其析出获得改性玉米醇溶蛋白纤维;2g of zein and 0.5g of ethyl cellulose were dissolved in 10 mL of 70% ethanol aqueous solution, filled with N2 , bagged and irradiated with an absorbed dose of 80 kGy, and then precipitated to obtain modified corn gliadin fibers;
将2g BaFe12O19纳米颗粒和1g改性玉米醇溶蛋白纤维混合搅拌30min,分散均匀后放入模具压铸成40mm×40mm×1mm膜体,并在2T磁场强度下进行充磁处理得到BFO-Zein/EC磁性膜。2g BaFe 12 O 19 nanoparticles and 1g modified zein fibers were mixed and stirred for 30 minutes, and then put into a mold for uniform dispersion and die-casting into a 40mm×40mm×1mm film body, and magnetized at 2T magnetic field intensity to obtain BFO- Zein/EC Magnetic Film.
实施例2Example 2
将15g FeCl3·6H2O和1.1g BaCl2·2H2O溶解在100mL去离子水中,在70℃下加入8g氢氧化钠持续搅拌4h后加入1.5mL油酸继续搅拌1h,得前驱体;将所得前驱体以9000r/min、75℃离心干燥11h后在1000℃下煅烧2.5h得到BaFe12O19纳米颗粒;Dissolve 15g FeCl 3 ·6H 2 O and 1.1g BaCl 2 ·2H 2 O in 100mL deionized water, add 8g sodium hydroxide at 70°C and continue stirring for 4h, then add 1.5mL oleic acid and continue stirring for 1h to obtain the precursor; The obtained precursor was centrifuged and dried at 9000 r/min at 75 °C for 11 h, and then calcined at 1000 °C for 2.5 h to obtain BaFe 12 O 19 nanoparticles;
将2.5g玉米醇溶蛋白与1g乙基纤维素溶解在10mL体积浓度为80%的乙醇水溶液中充N2装袋并进行辐照改性,吸收剂量为60kGy,之后将其析出获得改性玉米醇溶蛋白纤维;2.5g of zein and 1g of ethyl cellulose were dissolved in 10mL of 80% ethanol aqueous solution, filled with N2 , bagged and irradiated with an absorbed dose of 60kGy, and then precipitated to obtain modified corn gliadin fibers;
将1g BaFe12O19纳米颗粒和1g改性玉米醇溶蛋白纤维混合搅拌30min,分散均匀后放入模具压铸成40mm×40mm×1mm膜体,并在2T磁场强度下进行充磁处理得到BFO-Zein/EC磁性膜。1g BaFe 12 O 19 nanoparticles and 1g modified zein fibers were mixed and stirred for 30 minutes, and then put into a mold to be die-casted into a 40mm×40mm×1mm film body after uniform dispersion, and magnetized under 2T magnetic field intensity to obtain BFO- Zein/EC Magnetic Film.
对比例1Comparative Example 1
将16.2g FeCl3·6H2O和1.465g BaCl2·2H2O溶解在100mL去离子水中,在60℃下加入10g氢氧化钠持续搅拌4h后加入2mL油酸继续搅拌1h,得前驱体;将所得前驱体以5000r/min、80℃离心干燥12h后在900℃下煅烧2h得到BaFe12O19纳米颗粒;Dissolve 16.2g FeCl 3 ·6H 2 O and 1.465g BaCl 2 ·2H 2 O in 100mL deionized water, add 10g sodium hydroxide at 60°C and continue stirring for 4h, then add 2mL oleic acid and continue stirring for 1h to obtain the precursor; The obtained precursor was centrifuged and dried at 5000 r/min at 80 °C for 12 h, and then calcined at 900 °C for 2 h to obtain BaFe 12 O 19 nanoparticles;
将2.5g玉米醇溶蛋白溶解在10mL体积浓度为70%的乙醇水溶液中充N2装袋并进行辐照改性,吸收剂量为80kGy,之后将其析出获得改性玉米醇溶蛋白纤维;Dissolve 2.5g of zein in 10mL of an aqueous ethanol solution with a volume concentration of 70%, fill it with N, bag it, and carry out irradiation modification, the absorbed dose is 80kGy , and then separate it out to obtain modified zein fibers;
将2g BaFe12O19纳米颗粒和1g改性玉米醇溶蛋白纤维搅拌30min,分散均匀后放入模具压铸成40mm×40mm×1mm膜体,并进行充磁处理得到BFO-Zein磁性膜。2g of BaFe 12 O 19 nanoparticles and 1g of modified zein fibers were stirred for 30min, dispersed uniformly and then put into a mold for die casting into a 40mm×40mm×1mm film body, and magnetized to obtain a BFO-Zein magnetic film.
对比例2Comparative Example 2
将16.2g FeCl3·6H2O和1.465g BaCl2·2H2O溶解在100mL去离子水水中,在60℃下加入10g氢氧化钠持续搅拌4h后加入2mL油酸继续搅拌1h,得前驱体;将所得前驱体以5000r/min、80℃离心干燥12h后在900℃下煅烧2小时得到BaFe12O19纳米颗粒,记为BFONPs。Dissolve 16.2 g FeCl 3 ·6H 2 O and 1.465 g BaCl 2 ·2H 2 O in 100 mL of deionized water, add 10 g of sodium hydroxide at 60°C and continue stirring for 4 hours, then add 2 mL of oleic acid and continue stirring for 1 hour to obtain the precursor ; The obtained precursor was centrifuged and dried at 5000 r/min at 80 °C for 12 h, and then calcined at 900 °C for 2 h to obtain BaFe 12 O 19 nanoparticles, which were denoted as BFONPs.
对实施例1、对比例1~2所得材料进行检测,所得结果如图1~3所示。The materials obtained in Example 1 and Comparative Examples 1-2 were tested, and the obtained results are shown in Figures 1-3.
由图1可知,BFO NPs在2θ=30.3、32.2、34.1、37.1、40.3、42.4、55.1、56.3、56.6、63.1处均有明显特征衍射峰,对应于BaFe12O19纳米颗粒;而本发明所得BFO-Zein/EC磁性膜的衍射峰在图谱中也十分显著,说明磁性颗粒在磁性膜中占比较大,具有良好的磁力性能。It can be seen from Figure 1 that the BFO NPs have obvious characteristic diffraction peaks at 2θ=30.3, 32.2, 34.1, 37.1, 40.3, 42.4, 55.1, 56.3, 56.6, 63.1, corresponding to BaFe 12 O 19 nanoparticles; The diffraction peaks of the BFO-Zein/EC magnetic film are also very significant in the spectrum, indicating that the magnetic particles account for a large proportion in the magnetic film and have good magnetic properties.
由图2可知,使用油酸修饰后,钡铁氧体纳米颗粒大小分布均匀,分散性较好,晶相为片状六方晶,尺寸范围为50-200nm之间,处于单畴临界尺寸(460nm)与超顺磁临界尺寸(14nm)范围内;使用纤维素改性后磁性膜表面形成约200nm的脊脉,使材料产生超疏水性,进而使膜的水稳定性大大提高,同时钡铁氧体在磁性膜上均匀分布。说明本发明所得BFO-Zein/EC磁性膜与BFO-Zein磁性膜和BFO NPs相比具有更优异的稳定性和磁力性能。It can be seen from Figure 2 that after the modification with oleic acid, the size distribution of barium ferrite nanoparticles is uniform and the dispersibility is good. ) and the superparamagnetic critical size (14nm) range; ridges of about 200nm are formed on the surface of the magnetic film after cellulose modification, which makes the material superhydrophobic, thereby greatly improving the water stability of the film, while barium ferrite The body is evenly distributed on the magnetic film. It shows that the BFO-Zein/EC magnetic film obtained in the present invention has better stability and magnetic properties than BFO-Zein magnetic film and BFO NPs.
由图3可知,本发明所得BFO-Zein/EC磁性膜饱和磁化强度为44.75emu/g,剩磁24.84emu/g,矫顽力为-4.8k;而BFO NPs的饱和磁化强度为65.19emu/g,剩磁33.32emu/g,矫顽力为-4.8k;BFO-Zein磁性膜饱和磁化强度为43.32emu/g,剩磁为23.41emu/g,矫顽力均为-4.8k。It can be seen from Figure 3 that the saturation magnetization of the BFO-Zein/EC magnetic film obtained by the present invention is 44.75emu/g, the remanence is 24.84emu/g, and the coercivity is -4.8k; while the saturation magnetization of the BFO NPs is 65.19emu/g g, the remanence is 33.32emu/g, the coercivity is -4.8k; the saturation magnetization of the BFO-Zein magnetic film is 43.32emu/g, the remanence is 23.41emu/g, and the coercivity is -4.8k.
本发明所得BFO-Zein/EC磁性膜不仅具有优异的磁力性能,还具有很高的稳定性,磁性在较长时间内均能保持稳定,对铁磁性颗粒有明显的吸附聚集作用,对内源磁性靶向的发展有积极的意义,可用于慢性疾病的体内持续药物靶向。The BFO-Zein/EC magnetic film obtained by the invention not only has excellent magnetic properties, but also has high stability. The development of magnetic targeting has positive implications for sustained drug targeting of chronic diseases in vivo.
以上所述仅是本发明的优选实施方式,应当指出,对于本技术领域的普通技术人员来说,在不脱离本发明原理的前提下,还可以做出若干改进和润饰,这些改进和润饰也应视为本发明的保护范围。The above are only the preferred embodiments of the present invention. It should be pointed out that for those skilled in the art, without departing from the principles of the present invention, several improvements and modifications can be made. It should be regarded as the protection scope of the present invention.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210566407.5A CN114931638B (en) | 2022-05-24 | 2022-05-24 | BFO-Zein/EC magnetic composite film material and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210566407.5A CN114931638B (en) | 2022-05-24 | 2022-05-24 | BFO-Zein/EC magnetic composite film material and preparation method and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114931638A true CN114931638A (en) | 2022-08-23 |
CN114931638B CN114931638B (en) | 2023-07-04 |
Family
ID=82863680
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210566407.5A Active CN114931638B (en) | 2022-05-24 | 2022-05-24 | BFO-Zein/EC magnetic composite film material and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114931638B (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1879065A (en) * | 2003-09-12 | 2006-12-13 | 弗尔克斯破产财产公司 | Magnetically targetable particles comprising magnetic components and biocompatible polymers for site-specific delivery of biologically active agents |
CN106479196A (en) * | 2016-11-04 | 2017-03-08 | 金福兴 | A kind of antimicrobial packaging thin-film material and preparation method thereof |
US20180085496A1 (en) * | 2015-04-01 | 2018-03-29 | Yale University | Ferromagnetic particles bound to polymeric implants |
-
2022
- 2022-05-24 CN CN202210566407.5A patent/CN114931638B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1879065A (en) * | 2003-09-12 | 2006-12-13 | 弗尔克斯破产财产公司 | Magnetically targetable particles comprising magnetic components and biocompatible polymers for site-specific delivery of biologically active agents |
US20180085496A1 (en) * | 2015-04-01 | 2018-03-29 | Yale University | Ferromagnetic particles bound to polymeric implants |
CN106479196A (en) * | 2016-11-04 | 2017-03-08 | 金福兴 | A kind of antimicrobial packaging thin-film material and preparation method thereof |
Non-Patent Citations (3)
Title |
---|
MARIN, TIFFANY等: "Bioactive films of zein/magnetite magnetically stimuli-responsive for controlled drug release", 《JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS》 * |
卢杭诣: "水稳定zein基电纺纤维的制备及其药物释放行为研究", 《中国优秀硕士学位论文全文数据库工程科技Ⅰ辑》 * |
高绪亮: "铁系氧化物纳米材料制备研究", 《中国优秀硕士学位论文全文数据库工程科技Ⅰ辑》 * |
Also Published As
Publication number | Publication date |
---|---|
CN114931638B (en) | 2023-07-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Ghanbari et al. | Effect of rosemary extract on the microstructure, phase evolution, and magnetic behavior of cobalt ferrite nanoparticles and its application on anti-cancer drug delivery | |
Sun et al. | Magnetic iron oxide nanoparticles: Synthesis and surface coating techniques for biomedical applications | |
Tadic et al. | Iron oxide nanochains coated with silica: Synthesis, surface effects and magnetic properties | |
Karimi et al. | pH-controlled sunitinib anticancer release from magnetic chitosan nanoparticles crosslinked with κ-carrageenan | |
CN104072762B (en) | The preparation method of the magnetic carbon nano-tube that the poly-Dopamine HCL in a kind of surface is modified | |
Li et al. | Facile synthesis of folic acid-functionalized iron oxide nanoparticles with ultrahigh relaxivity for targeted tumor MR imaging | |
Moorthy et al. | Fucoidan-coated core–shell magnetic mesoporous silica nanoparticles for chemotherapy and magnetic hyperthermia-based thermal therapy applications | |
CN107029251B (en) | A kind of single-layer molybdenum disulfide-zinc ferrite nanocomposite material and its preparation method and application | |
JP2011126876A (en) | Magnetic iron oxide microparticle powder, aqueous dispersion containing magnetic particles, and process for production of same | |
CN104610913A (en) | Preparation method of microwave absorbing material taking MOFs molecular structure as template | |
CN102850599A (en) | Magnetic chitosan/nanometer Fe3O4 composite material and its preparation method and application | |
CN106344937A (en) | Monolayer molybdenum disulfide-cobalt ferrite nanocomposite material as well as preparation method and application thereof | |
CN106328336B (en) | A kind of preparation method of the magnetic carbon nano-tube based on charge effect | |
Ma et al. | Facile synthesis of ultrasmall MnFe2O4 nanoparticles with high saturation magnetization for magnetic resonance imaging | |
CN108479732A (en) | A kind of Fe with nucleocapsid structure3O4/SiO2/ PPy complex microspheres and preparation method thereof | |
CN105435753B (en) | A kind of mesoporous magnetic high-molecular composite balls and the preparation method and application thereof | |
CN103303981B (en) | Ferroferric oxide nanoparticle as well as preparation method and application thereof | |
CN102436886B (en) | A method for preparing gold-coated magnetic composite nanoparticles | |
CN114931638A (en) | BFO-Zein/EC magnetic composite membrane material and preparation method and application thereof | |
Saatci et al. | Synthesis, characterization, and 5-fluorouracil release behavior of superparamagnetic γ-Fe2O3/ZnO hetero-nanostructures for biomedical applications | |
CN109867309B (en) | A kind of water-soluble magnetic iron oxide nanocrystal and preparation method thereof | |
Yu et al. | Size‐tunable synthesis of stable superparamagnetic iron oxide nanoparticles for potential biomedical applications | |
CN108545782B (en) | Preparation method of monodisperse ultra-low coercivity iron ferric oxide nanoflowers | |
Sun et al. | A magnetic, luminescent and mesoporous nanocomposite as protein drug Carrier | |
CN103553145B (en) | A kind of preparation method of double-deck decorated nanometer ferroferric oxide magnetic fluid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |